The biology of pulmonary aspergillus infections
1University of Aberdeen, School of Medicine and Dentistry, Division of Applied Medicine, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
Abstract:
Pulmonary aspergillus infections are mainly caused by Aspergillus fumigatus and can be classified based on clinical syndromes into saphrophytic infections, allergic disease and invasive disease. Invasive pulmonary aspergillosis, occurring in immunocompromised patients, reflects the most serious disease with a high case-fatality rate. Patients with cystic fibrosis and severe asthma might develop allergic bronchopulmonary aspergillosis, while saphrophytic infections are observed in patients with lung cavities mainly due to tuberculosis. Histopathologically, a differentiation can be made into angio-invasive and airway-invasive disease. If the host response is too weak or too strong, Aspergillus species are able to cause disease characterized either by damage from the fungus itself or through an exaggerated inflammatory response of the host, in both situations leading to overt disease associated with specific clinical signs and symptoms. The unraveling of the specific host - Aspergillus interaction has not been performed to a great extent and needs attention to improve the management of those clinical syndromes.
Insights
Pulmonary aspergillus infections, caused by Aspergillus fumigatus, range from saprophytic to invasive forms. Understanding the host-fungus interaction is crucial for managing these diverse lung diseases.
Area of Science:
- Mycology
- Pulmonology
- Immunology
Background:
- Pulmonary aspergillus infections are primarily caused by Aspergillus fumigatus.
- These infections manifest as saprophytic, allergic, or invasive diseases.
- Invasive pulmonary aspergillosis is a severe condition in immunocompromised individuals with high mortality.
Purpose of the Study:
- To classify pulmonary aspergillus infections based on clinical syndromes.
- To differentiate histopathological presentations into angio-invasive and airway-invasive disease.
- To highlight the need for further research into host-Aspergillus interactions for improved clinical management.
Main Methods:
- Clinical syndrome classification.
- Histopathological differentiation (angio-invasive vs. airway-invasive).
Main Results:
- Aspergillus infections present as saprophytic (in lung cavities), allergic (e.g., allergic bronchopulmonary aspergillosis in cystic fibrosis, severe asthma), or invasive (in immunocompromised patients).
- Disease severity correlates with host immune response: either insufficient defense or exaggerated inflammation.
- Both extremes of host response lead to overt disease with distinct clinical signs.
Conclusions:
- Pulmonary aspergillosis encompasses a spectrum of diseases influenced by host immunity.
- Effective management requires a deeper understanding of the specific host-Aspergillus interactions.
- Further research is essential to improve therapeutic strategies for all forms of pulmonary aspergillosis.
Related Concept Videos
Fungal Phylum Ascomycota
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Other Pulmonary Disorders


